CAMEROON PHARMACEUTICAL MARKET

KEY FINDINGS

• The demand for pharmaceuticals is influenced by factors like disease prevalence, access to healthcare, and government healthcare policies.

• Cameroon has some local pharmaceutical manufacturing companies. However, the country still relies on imports for a significant portion of its pharmaceutical products.

• As per Volza’s Cameroon Import data, Pharmaceutical import shipments in Cameroon stood at 7.8K, imported by 292 Cameroon Importers from 209 Suppliers.

• Cameroon imports most of its Pharmaceutical from India, France and Belgium.

• The top 3 importers of Pharmaceutical are India with 501,461 shipments followed by the United States with 226,324 and Pakistan at the 3rd spot with 204,667 shipments.

• Challenges in the pharmaceutical sector in Cameroon may include issues related to counterfeit drugs, regulatory compliance, and infrastructure limitations.

• International pharmaceutical companies may engage in partnerships or investments in Cameroon to tap into the market's potential. Collaboration with local companies and healthcare institutions is also common.

• The degree of pharmaceutical products used in the country – estimated at up to 40% of regular products on the market – comes from contraband and illicit supply chains.

• As Cameroon pursues this Short-Term Plan of Action to develop its pharmaceutical productivity, ECA is encouraging the country to take advantage of its Africa Pharma initiative commissioned

• Pharmaceutical activities in Cameroon are dominated by the public sector, the private sector, and traditional pharmacopeia.

• The Health Care eCommerce market is a sub-market of the Care Products market. Further categories within the Care Products market are: Household Care, and Personal Care.

CAMEROON PHARMACEUTICAL MARKET MARKET OVERVIEW

The pharmaceutical market in Cameroon has been growing, driven by factors such as an increasing population, rising healthcare awareness, and a growing middle class.

Currently, local production meets only 5% of the national needs, as Cameroon imports over 90% of its needed pharmaceuticals.

ECA and Cameroonian experts agree that three main issues are responsible for stunting the growth of the pharmaceutical sector, which structural weakness made the country, like its African counterparts. These are: the lack of competitiveness, reputational issues and limited levels of partnership.

ECA is already brokering a possible partnership between the Government of Cameroon and the Africa Finance Corporation (AFC), which has demonstrated expertise in supporting and co-developing special economic zones and other industrial clusters in Africa.

in November 2019 in collaboration with the African Union Commission (AUC), the African Union Development Agency (AUDA-NEPAD), WHO, UNAIDS and other partners to improve Africa’s collective bargain for the timely and cost-effective procurement of medicines from elsewhere, while developing the continent’s own capacity to quickly produce its own medicines and strengthen its quality standards.

With technical support from the United Nations Economic Commission for Africa (ECA), public and private sector representatives have consolidated a comprehensive framework to render Cameroon’s local pharmaceutical sector better structured, resilient, productive, competitive and viable in the short term.

In the Cameroonian Health Care retail market, the online share is 2.1% and will increase by an average of 13.0% to 3.4% by 2027.

Generics are the most popular type of drug in Cameroon, accounting for over 70% of total sales. This is because generics are significantly cheaper than branded drugs.

The government is taking steps to develop the domestic pharmaceutical industry. This includes investing in research and development, providing tax incentives to pharmaceutical companies, and developing training programs for pharmacists.

INTRODUCTION

Cameroon has outlined a comprehensive strategy to seize a sizable portion of the local pharmaceutical market as well as the subregional and Nigerian markets of the Economic Community of Central African States (ECCAS).

The rapid innovation of modern technology has given rise to new legislative needs, in order to safeguard human health and the environment while at the same time taking advantage of the opportunities offered by technology. 

Centre National d’ Approvisionnement en Medicaments Essential's (CENAME) is the main public actor involved in the pharmaceutical industry in Cameroon after the Ministry of Health (MoH).

The OTC (over-the-counter) pharmaceuticals market is the largest segment of the market, accounting for over 50% of total revenue. This is due to the fact that OTC drugs are more affordable and accessible than prescription drugs.

The United Nations Economic Commission for Africa (ECA) and representatives from both the public and private sectors endorse this framework.

It aims to improve the local pharmaceutical industry’s structure, resilience, productivity, competitiveness, and short-term viability.

Currently, Cameroon imports over 90% of its pharmaceutical requirements, so local production only meets 5% of national requirements. The drug items utilized in the nation of ordinary items available comes from stash and illegal stockpile chains, as per the ECA. 

CAMEROON PHARMACEUTICAL MARKET SIZE AND FORECAST

The Cameroon Pharmaceutical Market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

CAMEROON PHARMACEUTICAL MARKET TRENDS

Cameroon's Ministry of Health partners with WHO to combat counterfeit drugs:In October 2023, the Cameroon Ministry of Health announced a new partnership with the World Health Organization (WHO) to combat the proliferation of counterfeit drugs in the country. The partnership will focus on raising awareness of the dangers of counterfeit drugs, strengthening drug regulatory systems, and enhancing enforcement efforts.

Growing demand for generics:Generics are becoming increasingly popular in Cameroon due to their affordability and effectiveness. This trend is expected to continue in the coming years, driven by rising healthcare costs and increasing consumer awareness of generic drugs.

Increasing adoption of e-commerce for pharmaceuticals:E-commerce is becoming increasingly popular for the purchase of pharmaceuticals in Cameroon. This is due to the convenience and affordability of online shopping, as well as the growing availability of e-commerce platforms in the country.

Government of Cameroon approves new regulations for pharmaceutical advertising:In August 2023, the government of Cameroon approved new regulations for pharmaceutical advertising. The new regulations aim to ensure that pharmaceutical advertising is truthful, balanced, and not misleading.

Cameroon signs agreement with India to strengthen pharmaceutical cooperation:In July 2023, Cameroon and India signed an agreement to strengthen cooperation in the pharmaceutical sector. The agreement includes provisions for the exchange of expertise, training of personnel, and joint research and development projects.

CAMEROON PHARMACEUTICAL MARKET NEW PRODUCT LAUNCH

Sanofi's new malaria treatment, Sulfadoxine-Pyrimethamine

Sulfadoxine-Pyrimethamine is a fixed-dose combination of two antimalarial drugs that is expected to be more effective and affordable than existing treatments.

Novartis' new HIV treatment, dolutegravir 50mg/300mg/100mg

Dolutegravir 50mg/300mg/100mg is a single-tablet regimen for the treatment of HIV-1 infection in adults and children weighing at least 30 kg.

Pfizer's new pneumococcal vaccine, Prevnar 13

Prevnar 13 is a vaccine that protects against 13 serotypes of pneumococcal bacteria, which can cause pneumonia, meningitis, and sepsis.

Roche's new hemophilia A treatment, Hemlibra: 

Hemlibra is a new bispecific antibody for the treatment of hemophilia A that is expected to be more effective and convenient than existing treatments. 

CAMEROON PHARMACEUTICAL MARKET SEGMENTATION

CAMEROON PHARMACEUTICAL MARKET By Demographic

• Age 
• Gender
• Location

CAMEROON PHARMACEUTICAL MARKET By Psychographic

• Health consciousness
• Lifestyle
• Brand Loyalty

CAMEROON PHARMACEUTICAL MARKET By Behavioral 

• Purchase behavior
• Price sensitivity
• Brand Awareness

CAMEROON PHARMACEUTICAL MARKET By Geographic

• Urban Area
• Rural Area
• Northern regions

CAMEROON PHARMACEUTICAL MARKET COMPANY PROFILE

• Abbvie
• Astrazeneca
• Bristol Myers Squibb
• GSK
• Johnson & Johnson
• Merck & Co
• Novartis
• Pfizer
• Roche Holding
• Sanofi

THIS CAMEROON PHARMACEUTICAL MARKET  REPORT WILL ANSWER FOLLOWING QUESTIONS

1. What is the current size and growth rate of the Cameroon pharmaceutical market?
2. What are the major challenges facing the Cameroon pharmaceutical market?
3. What are the key trends shaping the future of the Cameroon pharmaceutical market?
4. What are the different segments of the Cameroon pharmaceutical market?
5. What is the market share of each segment?
6. What are the key trends and drivers within each segment?
7. What are the unmet needs and opportunities within each segment?
8. Who are the major players in the Cameroon pharmaceutical market?
9. What are the market shares of the major players?
10. What are the competitive strengths and weaknesses of the major players?
11. What are the key strategies being pursued by the major players?
12. What is the regulatory environment for the pharmaceutical industry in Cameroon?
13. What are the key challenges and opportunities for pharmaceutical companies operating in Cameroon?
14. What is the level of access to essential medicines in Cameroon?
15. What are the barriers to access to essential medicines in Cameroon?
16. What are the government initiatives to improve access to essential medicines in Cameroon?
17. What role can pharmaceutical companies play in improving access to essential medicines in Cameroon?
18. What is the expected growth rate of the Cameroon pharmaceutical market in the next five years?
19. What are the key factors that will drive growth in the Cameroon pharmaceutical market in the next five years?
20. What are the key challenges that the Cameroon pharmaceutical market will face in the next five years?
21. What are the opportunities for investors and pharmaceutical companies in the Cameroon pharmaceutical market in the next five years?